期刊文献+

siRNA沉默CD55基因对胰腺癌BxPC-3细胞生物学行为的影响 被引量:3

Effect of siRNA-mediated silencing of the accelerating factor(CD55) on biological behaviour of human pancreatic cancer cell line BxPC-3
下载PDF
导出
摘要 目的探讨小分子干扰RNA(siRNA)沉默衰亡加速因子(CD55)基因对胰腺癌细胞增殖的影响。方法针对CD55基因设计3对siRNA,转染胰腺癌BxPC-3细胞,用实时定量PCR和Western blot检测CD55 mRNA和蛋白的表达,并用流式细胞术检测细胞生物学行为的改变。结果转染BxPC-3细胞48 h后,3条siRNA中仅siRNA3能显著抑制CD55 mRNA和蛋白的表达,细胞凋亡比率显著增加(P<0.05);细胞增殖率显著减少(P<0.05);细胞G1/G0期升高,G2期变化不明显,S期下降(P<0.05)。结论使用siRNA能够有效地沉默CD55基因的表达,并显著影响胰腺癌细胞的生物学行为。 Objective To study the specific effect of silencing of CD55 gene by small interfering RNA (siRNA) on the growth of human pancreatic cancer cell line BxPC-3.Methods Three CD55-specific siRNAs and one negative siRNA were designed and then transfected into human pancreatic cancer cell line BxPC-3 by Lipofectamine 2000.Quantitative real-time PCR(qRT-PCR) and Western blot were used to check the expression of CD55 mRNA and protein respectively.And flow cytometry were used to detect apoptosis,proliferation and cell cycle of target cells.Results One of three CD55-specific siRNAs,siRNA3 silenced the expression of the CD55 gene.The expression of CD55 mRNA and protein remarkably decreased.The cells transfected with siRNA3 were found to increase apoptosis and reduce proliferation significantly (P 〈 0.05) ; the target cells stagnated in phase G1 after transfection (P 〈 0.05).Conclusions siRNA-mediated silencing of CD55 can effectively affect the biological behavior of human pancreatic cancer cell line BxPC-3.
出处 《基础医学与临床》 CSCD 北大核心 2014年第7期974-978,共5页 Basic and Clinical Medicine
关键词 胰腺癌 RNA干扰 CD55 细胞凋亡 细胞增殖 细胞周期 pancreatic carcinoma RNA interference CD55 cell apoptosis cell proliferation cell cycle
  • 相关文献

参考文献4

二级参考文献40

  • 1Jemal ASR,Ward E,Murray T,et al.Cancer statistics[J] CA Cancer J Clin,2006,56:106-130.
  • 2Kleeff J M C,Friess H,Büchler MW.Pancreatic cancer:from bench to 5-year survival[J] Pancreas,2006,33:111-118.
  • 3Giatromanolaki A,Koukourakis MI,Sivridis E,et al.DEC1(STRA13)protein expression relates to hypoxia-in-ducible factor 1-alpha and carbonic anhydrase-9 overexpres-sion in non-small cell lung cancer[J] J Pathol,2003,200:222-228.
  • 4Li Y,Zhang H,Xie M,et al.Abundant expression ofDec1/stra13/sharp2 in colon carcinoma:its antagonizingrole in serum deprivation-induced apoptosis and selectiveinhibition of procaspase activation[J] Biochem J,2002,367:413-422.
  • 5Chakrabarti J,Turley H,Campo L,et al.The transcriptionfactor DEC1(stra13,SHARP2)is associated with the hy-poxic response and high tumour grade in human breastcancers[J] Br J Cancer,2004,91:954-958.
  • 6Sato FBU,Kawamoto T,Fujimoto K,et al.Basic-helix-loop-helix(bHLH)transcription factor DEC2 negativelyregulates vascular endothelial growth factor expression[J] Genes Cells,2008,13:131-144.
  • 7Noshiro MUE,Kawamoto T,Sato F,et al.Liver X recep-tors(LXRalpha and LXRbeta)are potent regulators for he-patic Dec1 expression[J] Genes Cells,2009,14:29-40.
  • 8Guillaumond F L S,Dulong S,Grechez-Cassiau A,et al.Altered Stra13 and Dec2 circadian gene expression in hy-poxic cells[J] Biochem Biophys Res Commun,2008,369:1184-1189.
  • 9Ehata SHA,Hayashi M,Aburatani H,et al.Transforminggrowth factor-beta promotes survival of mammary carcinomacells through induction of antiapoptotic transcription factorDEC1[J] Cancer Res,2007,67:9694-9703.
  • 10Lundgren K N B,Landberg G.Hypoxia,Snail and incom-plete epithelial-mesenchymal transition in breast cancer[J] Br J Cancer,2009,101:1769-1781.

共引文献6

同被引文献25

  • 1Gao Y, Shi Q, Xu S, et al. Cureumin promotes KLF5 pro- teasome degradation through down-regulating YAP/TAZ in bladder cancer ceils [J]. Int J Mol Sci, 2014, 15: 15173- 15187.
  • 2Mayer S, Hirschfeld M, Jaeger M, et al. RON alternative splicing regulation in primary ovarian cancer [J]. Oncol Rep, 2015, 34: 423-430.
  • 3Zhou DH, Li C, Yang LN. Variant RONDeltal60 of the RON receptor tyrosine kinase promotes the growth and inva- sion in vitro and in vivo in gastric cancer cell lines [ J ]. Cancer Cell Int, 2015, 15: 9-17.
  • 4Cheng HL, Liu HS, Lin YJ, et al. Co-expression of RON and MET is a prognostic indicator for patients with transi- tional-ceil carcinoma of the bladder [J]. Br J Cancer, 2005, 92: 1906-1914.
  • 5Yao HP, Zhou YQ, Zhang R, et al. MSP-RON signaling in cancer: pathogenesis and therapeutic potential [J]. Nat Rev Cancer, 2013, 13: 466-481.
  • 6Logan-Collins J, Thomas RM, Yu P, et al. Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers [J]. Cancer Res, 2010, 70: 1130-1140.
  • 7Rodriguez-Mora OG, Lahair MM, Mccubrey JA, et al. Cal- cium/calmodulin-dependent kinase I and calcium/calmodu- lin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells [ J]. Cancer Res, 2005, 65: 5408-5416.
  • 8O'Toole JM, Rabenau KE, Burns K, et al. Therapeutie implications of a human neutralizing antibody to the macro- phage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member [J]. Cancer Res, 2006, 66: 9162-9170.
  • 9Xu XM, Wang D, Shen Q, et al. RNA-mediated gene si- lencing of the RON receptor tyrosine kinase alters oncogen- ic phenotypes of human colorectal carcinoma cells [J]. Oncogene, 2004, 23: 8464-8474.
  • 10刘琪,潘翠翠,徐新,张彦懿,吴小候,罗春丽.5-氮-2'-脱氧胞苷逆转膀胱癌细胞hepaCAM基因的表达及对其生长的抑制[J].基础医学与临床,2013,33(1):55-59. 被引量:1

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部